Rxivist logo

Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports

By Julia Shapiro, Natalie E Dean, Zachary J. Madewell, Yang Yang, M. Elizabeth Halloran, Ira M Longini

Posted 21 May 2021
medRxiv DOI: 10.1101/2021.05.20.21257461

In this report, we provide summary estimates, from publications and reports, of vaccine efficacy (VE) for the COVID-19 vaccines that are being rolled out on a global scale. We find that, on average, the efficacy against any disease with infection is 85% (95% CI: 71 - 93%) after a full course of vaccination. The VE against severe disease, hospitalization or death averages close to 100%. The average VE against infection, regardless of symptoms, is 84% (95% CI: 70 - 91%). We also find that the average VE against transmission to others for Infected vaccinated people is 54% (95% CI: 38 - 66%). Finally, we prove summary estimates of the VE against any disease with infection for some of the variants of concern (VOC). The average VE for the VOC B.1.1.7, B.1.1.28 (P1) and B.1.351 are 86% (95% CI: 65 - 84%), 61% (95% CI: 43 - 73%) and 56% (95% CI: 29 - 73%), respectively.

Download data

  • Downloaded 20,278 times
  • Download rankings, all-time:
    • Site-wide: 429
    • In epidemiology: 74
  • Year to date:
    • Site-wide: 122
  • Since beginning of last month:
    • Site-wide: 607

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

News